Showing 581-590 of 1009 results for "".
Dermatologists Must Actively Address Disparities in Skin Cancer Diagnosis
https://practicaldermatology.com/issues/supplements/dermatologists-must-actively-address-disparities-in-skin-cancer-diagnosis/21717/Coral Reefs Under Siege: Is Sunscreen to Blame?
https://practicaldermatology.com/topics/practice-management/coral-reefs-under-siege-is-sunscreen-to-blame/20543/What the science says about the effects of sunscreens on marine life.Currents
https://practicaldermatology.com/topics/practice-management/currents/21227/Education is Key to Preventing Skin Cancers
https://practicaldermatology.com/topics/skin-cancer-photoprotection/education-is-key-to-preventing-skin-cancers/22938/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20454/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20965/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20790/Shedding Some Light on Hair Loss
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/shedding-some-light-on-hair-loss/23191/A look at the evolution of laser- and LED-assisted hair regrowth and the future of light therapy in the treatment of androgenetic alopeciaThe Do’s and Don’ts of Managing Pediatric Hidradenitis Suppurativa
https://practicaldermatology.com/topics/rare-disease/the-dos-and-donts-of-managing-pediatric-hidradenitis-suppurativa/54450/Pediatric HS is often underrecognized, especially in prepubertal children, leading to delayed treatment and preventable disease progression. Clinicians should adapt diagnostic criteria and proactively screen high-risk groups, such as patients with severe acne. Children with HS frequently have assocThe HRQoL Impact of Psoriasis: Perspectives for Value-Based Reimbursement
https://practicaldermatology.com/topics/psoriasis/the-hrqol-impact-of-psoriasis-perspectives-for-value-based-reimbursement/20932/Understanding the psychological/social burden of psoriasis on patients is critical as new therapeutics position themselves for reimbursement in a crowded and increasingly undifferentiated field.